<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320861">
  <stage>Registered</stage>
  <submitdate>23/11/2009</submitdate>
  <approvaldate>26/11/2009</approvaldate>
  <actrnumber>ACTRN12609001026213</actrnumber>
  <trial_identification>
    <studytitle>The effect of iodine supplementation on cognition in school-aged children</studytitle>
    <scientifictitle>Randomized, double-blind, placebo-controlled trial investigating the effect of iodine supplementation on cognition in school-aged children</scientifictitle>
    <utrn />
    <trialacronym>I-Learn Study</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Iodine deficiency</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A flavoured, chewable tablet containing 120 micrograms of iodine to be taken daily for 28 weeks</interventions>
    <comparator>A flavoured, chewable tablet containing placebo (identical to the active treatment with the exception of iodine content) to be taken daily for 28 weeks</comparator>
    <control>Placebo</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cognitive performance will be assessed using the Cambridge Neuropsychological Test Automated Battery (CANTAB)</outcome>
      <timepoint>Baseline and post-intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Iodine status and thyroid status will be assessed by the measurement of urinary iodine concentrations, thyroglobulin, free thyroxine, and thyrotropin levels.</outcome>
      <timepoint>Baseline, 4 weeks after commencement of the intervention, and at post-intervention</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Nutritional status will be assessed by a Food Frequency Questionnaire: The Australian Child and Adolescent Eating Survey</outcome>
      <timepoint>Baseline and post-intervention</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Use of iodized or non-iodized salt at home will be assessed by a Type of Salt Used at Home Checklist</outcome>
      <timepoint>Baseline and post-intervention</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Mildly iodine-deficient (i.e., a median urinary iodine concentration level of 50-99 micrograms per litre in the study population)
No history of thyroid disease
Not taking iodine-containing supplements</inclusivecriteria>
    <inclusiveminage>8</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>12</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>History of thyroid disease;
Taking iodine-containing supplements</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>The iodine and placebo tablets will be provided by the supplier in bottles labelled with code numbers using NQuery software. The research group will remain blinded to which experimental condition participants are allocated until the end of the study when the code will be broken</concealment>
    <sequence>Participants will be randomly allocated to receive bottles labelled with code numbers containing either iodine or placebo tablets using a random sequence generated by the RAND function in Microsoft Excel</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>3/05/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>350</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>5112</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Adelaide</primarysponsorname>
    <primarysponsoraddress>Robinson Institute
School of Paediatrics and Reproductive Health
Medical North Building, Level 6
University of Adelaide
Frome Road
ADELAIDE SA 5005</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Pollin Prize for Paediatric Research</fundingname>
      <fundingaddress>1150 St. Nicholas Ave, Room 620
New York, NY 10032</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Adelaide</sponsorname>
      <sponsoraddress>School of Psychology
Hughes Building, Level 4
University of Adelaide
North Terrace
ADELAIDE SA 5005</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study aims to examine the effect of iodine supplementation on cognition in mildly iodine-deficient school-aged children

The research hypothesis is that the cognitive test scores of children taking a daily iodine supplement will improve relative to baseline performance and compared to children taking a daily placebo over the 28-week trial period</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The University of Adelaide Human Research Ethics Committee</ethicname>
      <ethicaddress>The University of Adelaide
SA 5005</ethicaddress>
      <ethicapprovaldate>17/02/2010</ethicapprovaldate>
      <hrec>H-177-2009</hrec>
      <ethicsubmitdate>11/11/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Government of South Australia
Department of Education and Children's Services</ethicname>
      <ethicaddress>Policy Directorate
Education Centre
Level 8/31 Flinders Street
Adelaide SA 5000</ethicaddress>
      <ethicapprovaldate>29/04/2010</ethicapprovaldate>
      <hrec>DECS CS/10/250.3</hrec>
      <ethicsubmitdate>3/03/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Associate Professor Vicki Clifton</name>
      <address>Robinson Institute
Lyell McEwin Hospital
Haydown Road Elizabeth Vale SA 5112
Australia</address>
      <phone>+61 8 8133 2133</phone>
      <fax>+61 8 8182 9337</fax>
      <email>vicki.clifton@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Associate Professor Vicki Clifton</name>
      <address>Robinson Institute
Lyell McEwin Hospital
Haydown Road Elizabeth Vale SA 5112
Australia</address>
      <phone>+61 8 8133 2133</phone>
      <fax>+61 8 8182 9337</fax>
      <email>vicki.clifton@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Associate Professor Vicki Clifton</name>
      <address>Robinson Institute
Lyell McEwin Hospital
Haydown Road Elizabeth Vale SA 5112
Australia</address>
      <phone>+61 8 8133 2133</phone>
      <fax>+61 8 8182 9337</fax>
      <email>vicki.clifton@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>